Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021

  • Jonathan Schwartz,

Press/Media

Period14 Sep 2021

Media coverage

2

Media coverage

  • TitleRocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date14/09/21
    PersonsJonathan Schwartz,
  • TitleRocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021
    Media name/outletFirstWord Pharma
    Country/TerritoryUnited States
    Date14/09/21
    URLwww.firstwordpharma.com/node/1863465
    PersonsJonathan Schwartz,